MarketFriction

Lotus Eye Hospital & Institute Ltd

NSE LOTUSEYE · BSE 532998 · Hospital
₹115.68 -0.18%
NSE close2026-10-01
52 week range97.59 - 147.00
Market cap₹235 Cr.
P/E1,471
Price band 20% Delivery 87.7%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales12.7312.0310.8812.8912.9112.2511.5113.5213.0413.5513.6117.06
Expenses10.9210.4510.1211.2311.7611.4611.6812.0412.2712.8913.1314.11
Operating Profit1.811.580.761.661.150.79-0.171.480.770.660.482.95
OPM %14.22%13.13%6.99%12.88%8.91%6.45%-1.48%10.95%5.90%4.87%3.53%17.29%
Other Income0.280.340.400.310.270.220.520.190.270.240.470.21
Interest0.010.040.030.060.080.130.090.120.120.290.330.51
Depreciation0.890.981.121.061.231.31-0.580.820.850.981.101.64
Profit before tax1.190.900.010.850.11-0.430.840.730.07-0.37-0.481.01
Tax %28.57%26.67%-200.00%28.24%9.09%-44.19%70.24%24.66%-71.43%-29.73%-33.33%39.60%
Net Profit0.850.660.020.620.10-0.240.250.540.12-0.26-0.320.61
EPS in Rs0.410.320.010.300.05-0.120.120.260.06-0.13-0.150.29
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales31.1333.9638.0238.4340.5532.3538.9047.0348.2049.5553.7057.26
Expenses27.1430.6333.6835.2136.5728.7332.9839.3541.5745.9950.1552.40
Operating Profit3.993.334.343.223.983.625.927.686.633.563.554.86
OPM %12.82%9.81%11.42%8.38%9.82%11.19%15.22%16.33%13.76%7.18%6.61%8.49%
Other Income0.580.680.910.680.210.840.881.151.311.311.181.19
Interest0.160.150.180.210.240.140.210.200.200.481.031.25
Depreciation4.443.443.373.062.502.332.502.983.733.013.754.57
Profit before tax-0.030.421.700.631.451.994.095.654.011.38-0.050.23
Tax %-400.00%-7.14%-2.35%-12.70%26.90%21.11%27.14%27.79%27.43%46.38%-280.00%
Net Profit0.100.441.750.711.061.572.984.082.910.740.080.15
EPS in Rs0.050.210.840.340.510.751.431.961.400.360.040.07
Dividend Payout %0.00%236.36%59.43%0.00%0.00%66.24%34.90%25.49%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth6%11%5%14%
Compounded Profit Growth-1%-44%-73%-75%
Stock Price CAGR20%18%11%-4%
Return on Equity3%4%2%0%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital20.8020.8020.8020.8020.8020.8020.8020.8020.8020.8020.8020.80
Reserves28.5928.6929.2629.8429.3230.4631.9033.8136.7838.6139.2039.34
Borrowings0.830.660.480.290.220.320.401.240.671.113.4315.83
Other Liabilities6.204.684.407.286.186.536.125.754.936.116.146.63
Total Liabilities56.4254.8354.9458.2156.5258.1159.2261.6063.1866.6369.5782.60
Fixed Assets47.0443.5741.3242.5244.1442.6740.5444.0744.1848.6554.0765.81
CWIP0.270.420.650.290.290.000.000.000.000.080.000.09
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets9.1110.8412.9715.4012.0915.4418.6817.5319.0017.9015.5016.70
Total Assets56.4254.8354.9458.2156.5258.1159.2261.6063.1866.6369.5782.60
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity2.373.382.975.784.204.972.734.414.395.682.703.02
Cash from Investing Activity-4.65-0.85-1.06-3.86-4.01-0.680.49-3.94-2.19-4.63-6.13-14.39
Cash from Financing Activity1.87-0.58-0.25-1.51-1.410.13-0.32-1.58-1.71-3.40-1.609.03
Net Cash Flow-0.401.961.660.41-1.224.422.90-1.100.49-2.35-5.03-2.34
Free Cash Flow-2.382.281.551.58-0.493.542.61-0.251.300.10-2.09-10.01
CFO/OP109%85%92%142%134%132%84%89%76%101%94%94%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days4.275.987.3110.947.225.948.355.829.089.549.728.22
Inventory Days121.54113.2560.2279.23128.20124.42138.82150.03153.60170.30193.62172.16
Days Payable125.08105.5187.32129.95167.37170.41220.72231.21173.42183.56169.86146.09
Cash Conversion Cycle0.7313.72-19.79-39.78-31.95-40.05-73.54-75.37-10.74-3.7233.4834.30
Working Capital Days-19.90-8.56-8.92-26.02-15.39-21.33-23.92-16.338.615.680.00-12.17
ROCE %-4.23%0.24%1.19%3.63%1.66%4.67%3.92%7.91%10.25%7.07%2.99%1.41%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters57.58%56.58%41.40%40.24%40.03%40.14%40.22%40.39%40.63%40.66%40.14%40.14%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.01%0.00%0.00%
DIIs0.00%0.00%0.00%0.00%0.00%0.04%0.04%0.02%0.02%0.02%0.02%0.02%
Public42.43%43.42%58.60%59.76%59.97%59.82%59.73%59.57%59.33%59.31%59.85%59.85%
No. of Shareholders7,6608,31412,50211,75912,51411,73411,50811,12110,77710,2409,9399,627

Fundamentals

Market Cap₹ 235 Cr.
Current Price₹ 113
Stock P/E1,471
Book Value₹ 28.9
ROCE1.41 %
ROE0.13 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)14%
Compounded Profit Growth (TTM)-75%
Standalone figures.
Valuation
Market capRs 241 Cr
Enterprise valueRs 253 Cr
P/E (TTM)1603.81x
Price to book4.00x
Price to sales4.20x
EV / EBITDA41.75x
EV / EBIT170.66x
EV / sales4.41x
Price to cash flow79.66x
Earnings yield0.06%
P/E, 3-year average927.10x
P/B, 3-year average2.56x
P/E, 5-year average569.63x
P/B, 5-year average2.36x
Profitability
Operating margin (excl. other income)6.61%
Operating margin (incl. other income)8.81%
EBITDA margin10.57%
Pre-tax margin0.40%
Net profit margin0.26%
Net margin, latest quarter3.58%
ROE0.13%
ROCE1.41%
ROA0.11%
ROE, 3-year average2.12%
ROCE, 3-year average3.83%
ROA, 3-year average1.89%
ROE, 5-year average3.83%
ROCE, 5-year average5.93%
ROA, 5-year average3.43%
ROIC (approx.)-3.69%
Tax rate280.00%
Other income / net worth1.96%
Growth
Sales growth (latest year)8.38%
Profit growth (latest year)-89.19%
Sales CAGR, 3 years4.52%
Sales CAGR, 5 years10.67%
Profit CAGR, 3 years-73.03%
Profit CAGR, 5 years-44.86%
Sales growth QoQ25.35%
Sales growth YoY (latest quarter)26.18%
Profit growth YoY (latest quarter)12.96%
Per share
EPS (TTM)Rs 0.07
EPS (latest year)Rs 0.04
EPS (latest quarter)Rs 0.29
EPS, 3-year averageRs 0.60
EPS, 5-year averageRs 1.04
Book value per shareRs 28.92
Sales per shareRs 27.53
Cash flow per shareRs 1.45
Free cash flow per shareRs -4.81
Dividend per share, 5-year averageRs 0.50
Dividends
Dividend payout, 5-year average30.19%
Efficiency
Asset turnover0.65x
Fixed asset turnover0.82x
Inventory turnover8.14x
Inventory days45 days
Debtor days8 days
Debtors turnover44.38x
Creditor days146 days
Cash conversion cycle34 days
Working capital days-12 days
Leverage
Total debtRs 16 Cr
Cash and bankRs 4 Cr
Net debtRs 12 Cr
Debt to equity0.26x
Net debt / EBITDA1.98x
Interest coverage1.18x
Owners' fund to total sources72.81%
Debt to assets19.16%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs -14 Cr
Cash from Financing Activity (latest year)Rs 9 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs -10 Cr
FCFE (approx.: FCF + change in debt)Rs 2 Cr
Cash from ops / profit, 5 years1.87x
Sales to cash flow17.78x
Statement figures
Net sales (TTM)Rs 57 Cr
Net sales (latest year)Rs 54 Cr
Sales (latest quarter)Rs 17 Cr
Operating profit excl. other income (latest year)Rs 4 Cr
Operating profit (latest quarter)Rs 3 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 6 Cr
PBDT (TTM)Rs 5 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 5 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 31 Cr
Total expenditure (latest year)Rs 50 Cr
Total income (latest year)Rs 55 Cr
Share capitalRs 21 Cr
ReservesRs 39 Cr
Shareholders' fundsRs 60 Cr
Total assetsRs 83 Cr
Net blockRs 66 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 1 Cr
InventoryRs 4 Cr
Other liabilitiesRs 7 Cr
Shares outstanding (crore)2.08
Ownership
Promoter holding40.14% (-0.25 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 4.00 is at the 91th percentile (median 2.05).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodLOTUSEYENifty 50Difference
1 week+2.2%-2.8% +4.9 pts
1 month+6.4%-6.8% +13.1 pts
3 months-9.7%-7.6% -2.1 pts
6 months+17.8%+0.4% +17.4 pts
1 year-2.9%-9.9% +7.0 pts
2 years+55.8%-13.6% +69.3 pts
3 years+39.5%+14.2% +25.4 pts
5 years+140.5%+27.9% +112.6 pts

Red flags

F-score 4 of 8
seriousLow interest cover Interest cover 1.0x in 2026
explainDebt up, profit down Borrowings up 362% while net profit fell in 2026
lookAuditor change Auditor change 2026-05-26: Lotus Eye Hospital and Institute Limited has informed the Exchange regarding Change in Auditors of the company.
lookRegulator order or action Regulator order or action 2026-03-04: Lotus Eye Hospital and Institute Limited has informed the Exchange about Action(s) taken or orders passed
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹17 Cr +26.2% vs Jun 2025. Net profit ₹1 Cr +13.0%.
Against our estimate for Jun 2026: sales +10.3%, profit +889.7% beat. Our estimate for Sep 2026: sales Rs 16 Cr, profit Rs 0 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Apollo Hospitals Enterprise Ltd124,50359.217.4 %
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Aster DM Quality Care Ltd63,97617711.6 %
Fortis Healthcare Ltd62,05858.213.4 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Krishna Institute of Medical Sciences Ltd32,3361559.50 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Rainbow Childrens Medicare Ltd13,89248.517.4 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Healthcare Global Enterprises Ltd10,5052188.30 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
No bulk or block deals on record.
Ex-dateActionFactor
2023-09-18Dividend - Re 0.50 Per Share
2023-09-18Annual General Meeting
2022-09-08Annual General Meeting/Dividend - Re 0.50 Per Sh
2021-09-08 Annual General Meeting/Dividend - Rs 0.50 Per Share
2020-11-19 Annual General Meeting
2019-09-16 Annual General Meeting
2018-09-14 Annual General Meeting/Dividend Re 0.5 Per Share
2017-08-02 Annual General Meeting/Dividend - Re 0.50 Per Share
2016-08-23 Annual General Meeting
2015-09-18 Annual General Meeting
2014-09-16Annual General Meeting
2013-09-17Annual General Meeting
2012-09-14Annual General Meeting
2011-09-20Annual General Meeting
2010-09-08Annual General Meeting
2009-09-23Annual General Meeting
2008-09-24Annual General Meeting
DateTypeWhat it says
2026-09-24Shareholder meetingLOTUSEYE: Lotus Eye Hospital and Institute Limited has submitted Voting Results and Scrutinizers Report for the Annual General Meeting held on Septemb...
2026-09-23Shareholder meetingProceedings of Annual General Meeting held on September 23, 2026
2026-09-01Shareholder meeting29th Annual General Meeting scheduled to be held on September 23, 2026.
2026-08-27Press ReleaseA press release dated August 27, 2026, titled "Launch of Lotus Optique, a new optical store.".
2026-08-10Board meeting outcomeLOTUSEYE: Lotus Eye Hospital and Institute Limited has submitted to the Exchange, the Standalone Unaudited Financial Results for the period ended June...
2026-06-19Disclosure under SEBI TakeovLotus Eye Hospital and Institute Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Boar...
2026-06-05UpdatesThe financial results for the period ended March 31, 2026 in machine readable format.
2026-05-26Change in AuditorsChange in Auditors of the company.
2026-05-26Board meeting outcomeLotus Eye Hospital and Institute Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-04-18UpdatesNon-applicability of SEBI Circular on Large Corporates
2026-03-17Board meeting outcomeOutcome of Board Meeting held on March 17, 2026.
2026-03-04Regulatory actionAction(s) taken or orders passed
2026-03-02Disclosure under SEBI TakeovSangeetha Sundaramoorthy has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisi...
2026-02-12UpdatesBoard comments on imposition of fine under Regulation 17(1A) of SEBI (LODR), 2015.
2026-02-12Change in Company Secretary/Change in Company Secretary/Compliance Officer
2026-02-11Board meeting outcomeLotus Eye Hospital and Institute Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
2026-02-11Board meeting outcomeBoard meeting held on February 11, 2026.
2026-02-09ResignationResignation of M Achuth menon as Company Secretary & Compliance Officer of the company w.e.f. February 12, 2026.
2026-01-27Disclosure under SEBI TakeovSangeetha Sundaramoorthy has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Sub...
2026-01-19UpdatesResults of voting by postal ballot and scrutinizers report.
2025-12-24CorrigendumRevision in announcement made on 18.12.2025
2025-12-18Shareholder meetingNotice of Postal Ballot
2025-12-16AppointmentAppointment of as Independent Director of the company w.e.f. January 03, 2026.
2025-11-29Regulatory actionAction(s) taken or orders passed
2025-11-12Board meeting outcomeLotus Eye Hospital and Institute Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysScrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Lotus Eye Hospital & Institute Ltd?

Lotus Eye Hospital & Institute Ltd (LOTUSEYE) has a market capitalisation of Rs 235 Cr. at the 2026-10-01 close.

What is the P/E ratio of Lotus Eye Hospital & Institute Ltd?

Lotus Eye Hospital & Institute Ltd trades at a P/E of 1,471 on trailing twelve-month profit, at the 2026-10-01 close.

What were Lotus Eye Hospital & Institute Ltd's latest quarterly results?

In the Jun 2026 quarter, Lotus Eye Hospital & Institute Ltd sales was Rs 17 Cr (+26.2% vs Jun 2025) and net profit was Rs 1 Cr.

What is the 52-week high and low of Lotus Eye Hospital & Institute Ltd?

The 52-week high is Rs 147.00 and the 52-week low is Rs 97.59.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03